SCIENTISTS from the United States to Australia are using new technology in an ambitious, multi-million-dollar drive to develop a vaccine in record time to tackle China’s coronavirus outbreak. The new virus has spread rapidly since emerging late last year in China, killing more than 800 people in the mainland and infecting over 37,000.
Cases have been reported in two dozen other countries. Coming up with any vaccine typically takes years, and involves a lengthy process of testing on animals, clinical trials on humans and regulatory approvals. But several teams of experts are racing to develop one quicker, backed by an international coalition that aims to combat emerging diseases, and Australian scientists hope theirs could be ready in six months. “It is a high-pressure situation and there is a lot of weight on us,” said senior researcher Keith Chappell, part of the group from Australia’s University of Queensland.
But the scientist added he took “some solace” knowing several teams around the world were engaged in the same mission. “The hope is that one of these will be successful and can contain this outbreak,” he said. Efforts are being led by the Coalition for Epidemic Preparedness Innovations (CEPI), a body established in 2017 to finance costly biotechnology research in the wake of an Ebola outbreak in West Africa that killed more than 11,000 people.